Symtuza
RxNorm concept 2049672, brand name (bn).
- RxCUI
- 2049672
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2049672 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- darunavir ethanolate (PIN, has precise ingredient)
- tenofovir alafenamide fumarate (PIN, has precise ingredient)
- cobicistat 150 MG / darunavir 800 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG [Symtuza] (SBDC, ingredient of)
- cobicistat / darunavir / emtricitabine / tenofovir alafenamide Oral Tablet [Symtuza] (SBDF, ingredient of)
- Symtuza Oral Product (SBDG, ingredient of)
- Symtuza Pill (SBDG, ingredient of)
- cobicistat 150 MG / darunavir 800 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet [Symtuza] (SBD, ingredient of)
- emtricitabine (IN, tradename of)
- darunavir (IN, tradename of)
- cobicistat (IN, tradename of)
- tenofovir alafenamide (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2049672 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2049672 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2049672. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.